Exchange: NASDAQ·Updated 11:40 AM EDT
LYEL logo

LYEL Lyell Immunopharma Inc

$14.30
$0.23
(1.58%)
Today
Reported EarningsAug 12
Mkt Cap$356.06M
Vol13,154.00

About LYEL

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.
56

Bullish Sentiment

How do you feel about LYEL?

Advertisement|Remove ads.